Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carfilzomib Replacement in Bortezomib-Failing Multiple Myeloma
NCT01365559Phase 2Completed
- Sponsor
- ONCOtherapeutics
- Start
- May 2011
- Primary completion
- Jun 2014
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of carfilzomib in multiple myeloma (MM), sponsored by ONCOtherapeutics. Started May 2011; status: completed.
02
Drugs
carfilzomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01365559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01365559.